Altimmune Ownership | Who Owns Altimmune?

Overview Forecast RevenueFinancials Chart Transcripts

Altimmune Ownership Summary

Altimmune is owned by 55.57% institutional investors, 0.79% insiders, and 43.64% retail investors. Hennion & walsh asset management is the largest institutional shareholder, holding 0.29% of ALT shares. CT (Lux) American Smaller Com 9U USD is the top mutual fund, with 3.28% of its assets in Altimmune shares.

ALT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Altimmune	55.57%	0.79%	43.64%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Hennion & walsh asset management	205.59K	0.29%	$1.48M
Exchange traded concepts	159.57K	0.22%	$1.15M
Wealth effects	32.85K	0.05%	$236.85K
Kraematon investment advisors	30.79K	0.04%	$221.96K
Miracle mile advisors	17.00K	0.02%	$122.57K
China universal asset management	15.08K	0.02%	$108.73K
Pfg investments	13.30K	0.02%	$95.89K
180 wealth advisors	10.86K	0.02%	$78.27K
Wealth enhancement advisory services	9.63K	0.01%	$59.14K
Gamma investing	2.15K	0.00%	$15.48K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kraematon investment advisors	30.79K	0.22%	$221.96K
Wealth effects	32.85K	0.08%	$236.85K
Hennion & walsh asset management	205.59K	0.07%	$1.48M
Exchange traded concepts	159.57K	0.02%	$1.15M
180 wealth advisors	10.86K	0.01%	$78.27K
China universal asset management	15.08K	0.01%	$108.73K
Pfg investments	13.30K	0.01%	$95.89K
Activest wealth management	2.00K	0.00%	$14.43K
Miracle mile advisors	17.00K	0.00%	$122.57K
Pacific capital wealth advisors	1.39K	0.00%	$10.01K

Top Buyers

Holder	Shares	% Assets	Change
Hennion & walsh asset management	205.59K	0.07%	31.48K
Kraematon investment advisors	30.79K	0.22%	30.79K
China universal asset management	15.08K	0.01%	15.08K
Pfg investments	13.30K	0.01%	13.30K
180 wealth advisors	10.86K	0.01%	10.86K

Top Sellers

Holder	Shares	% Assets	Change
Exchange traded concepts	159.57K	0.02%	-57.19K
Janney montgomery scott	-	-	-22.93K
Brave asset management	-	-	-10.00K
Wealth effects	32.85K	0.08%	-2.20K
Gamma investing	2.15K	0.00%	-220.00

New Positions

Holder	Shares	% Assets	Change	Value
Kraematon investment advisors	30.79K	0.22%	30.79K	$221.96K
China universal asset management	15.08K	0.01%	15.08K	$108.73K
180 wealth advisors	10.86K	0.01%	10.86K	$78.27K
Massmutual trust co fsb/adv	162.00	-	162.00	$1.17K

Sold Out

Holder	Change
Advisornet financial	-100.00
Brave asset management	-10.00K
Janney montgomery scott	-22.93K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	180	-4.26%	39,499,260	-6.80%	55	1.56%	83	-17.82%	43	-6.52%
Jun 30, 2024	188	2.73%	42,381,900	-4.54%	59	1.04%	101	-4.72%	46	12.20%
Mar 31, 2024	183	22.00%	44,397,217	33.58%	75	1.98%	106	10.42%	41	78.26%
Dec 31, 2023	150	25.00%	33,236,130	9.54%	61	1.73%	96	104.26%	23	-41.03%
Sep 30, 2023	120	-6.25%	30,341,585	-13.91%	59	1.21%	47	-29.85%	39	18.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
CT (Lux) American Smaller Com 9U USD	2.33M	3.28%	391.34K
Vanguard Total Stock Mkt Idx Inv	2.24M	3.15%	-
iShares Russell 2000 ETF	1.91M	2.69%	-7.35K
SPDR® S&P Biotech ETF	1.80M	2.53%	-20.99K
CT American Smaller Coms(US) InstAccGBP	1.77M	2.49%	-28.91K
Vanguard Institutional Extnd Mkt Idx Tr	1.12M	1.58%	24.33K
Fidelity Small Cap Index	726.71K	1.02%	3.63K
Bellevue Healthcare Ord	600.00K	0.84%	600.00K
International Biotechnology Ord	473.87K	0.67%	-
iShares Biotechnology ETF	456.26K	0.64%	-3.29K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 19, 2024	Drutz David	-	Sell	$54.24K
Aug 19, 2024	Drutz David	-	Sell	$56.31K
Aug 15, 2023	Drutz David	-	Buy	$862.50
Aug 12, 2022	GILL JOHN	-	Sell	$40.71K
Mar 23, 2023	Drutz David	-	Buy	$38.43K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	2
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

ALT Ownership FAQ

Who Owns Altimmune?

Altimmune shareholders are primarily institutional investors at 55.57%, followed by 0.79% insiders and 43.64% retail investors. The average institutional ownership in Altimmune's industry, Biotech Stocks , is 109.70%, which Altimmune falls below.

Who owns the most shares of Altimmune?

Altimmune’s largest shareholders are Hennion & walsh asset management (205.59K shares, 0.29%), Exchange traded concepts (159.57K shares, 0.22%), and Wealth effects (32.85K shares, 0.05%). Together, they hold 0.56% of Altimmune’s total shares outstanding.

Does Blackrock own Altimmune?

BlackRock is not among the top 10 institutional shareholders of Altimmune.

Who is Altimmune’s biggest shareholder by percentage of total assets invested?

Kraematon investment advisors is Altimmune’s biggest shareholder by percentage of total assets invested, with 0.22% of its assets in 30.78K Altimmune shares, valued at 221.96K$.

Who is the top mutual fund holder of Altimmune shares?

CT (Lux) American Smaller Com 9U USD is the top mutual fund holder of Altimmune shares, with 3.28% of its total shares outstanding invested in 2.33M Altimmune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools